What is the proper use of Narcan (naloxone) in an opioid overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Proper Use of Naloxone (Narcan) in Opioid Overdose

For suspected opioid overdose, immediately activate the emergency response system, provide rescue breathing or CPR as needed, and administer naloxone while not delaying standard resuscitation measures. 1

Initial Assessment and Response

  1. Recognition of opioid overdose:

    • Unresponsiveness
    • Respiratory depression or arrest (slow, shallow, or absent breathing)
    • Pinpoint pupils (miosis)
    • Cyanosis
    • Evidence of opioid use nearby
  2. Immediate actions (in order):

    • Activate emergency response system (call 911) 1
    • Assess breathing and pulse 1
    • If no normal breathing but has pulse: Begin rescue breathing 1
    • If no pulse: Begin high-quality CPR with compressions plus ventilation 1
    • Administer naloxone while continuing resuscitation efforts 1

Naloxone Administration

Routes of Administration

  • Intranasal (IN): Preferred for lay responders and first aid providers

    • Spray directly into one nostril (2-4 mg) 2
    • No assembly required with FDA-approved devices
  • Intramuscular (IM): Alternative when IN not available

    • Inject into large muscle (thigh or upper arm)
    • Standard dose: 0.4-2 mg 3
  • Intravenous (IV): Fastest onset, typically used by healthcare providers

    • Initial dose: 0.4-2 mg 3
    • May be titrated in smaller increments (0.1-0.2 mg) for postoperative opioid depression 3

Dosing Considerations

  • Initial dose:

    • For suspected overdose: 2-4 mg IN or 0.4-2 mg IM/IV 1, 3
    • For respiratory depression with known pulse: Same as above
  • Repeat dosing:

    • If inadequate response, repeat dose every 2-3 minutes 1, 4
    • Multiple doses are often necessary, especially with potent synthetic opioids like fentanyl 5
    • 78% of community reversals required ≥2 doses of naloxone 5

Post-Administration Care

  1. Monitor response:

    • Most patients respond within 5 minutes (73.5% of cases) 2
    • Continue rescue breathing/CPR until spontaneous breathing returns 1
    • Be prepared for possible opioid withdrawal symptoms
  2. Observation period:

    • All patients must be observed in a healthcare setting after naloxone administration 1
    • Duration of naloxone (30-45 minutes) is shorter than many opioids 1, 4
    • Recurrent respiratory depression may occur as naloxone wears off 1
  3. Potential for withdrawal:

    • Common symptoms include agitation, nausea, vomiting, sweating, and tachycardia 1
    • Use lowest effective dose to minimize withdrawal severity 1
    • Withdrawal symptoms are rarely life-threatening 1

Special Considerations

  • Potent synthetic opioids (e.g., fentanyl):

    • May require higher total doses or multiple administrations 4, 5
    • 95.4% of community reversals involved heroin; 5.2% involved fentanyl 2
  • Polysubstance overdose:

    • Naloxone only reverses opioid effects, not other substances 4
    • Continue supportive care regardless of naloxone response
  • Lay responder training:

    • Training in opioid overdose recognition and naloxone administration is beneficial 1
    • Hands-on training is more effective than video-only instruction 1

Common Pitfalls to Avoid

  1. Delaying CPR while searching for naloxone - Always prioritize standard resuscitation measures 1
  2. Premature discharge - Observation is required due to naloxone's shorter duration of action 1
  3. Focusing on consciousness rather than adequate ventilation - The primary goal is to restore breathing 1
  4. Inadequate dosing - Modern synthetic opioids may require multiple doses 4, 5
  5. Not activating emergency services - All overdose patients need medical evaluation 1

Effectiveness and Safety

  • Successful reversal reported in 98.8% of community-administered cases 2
  • Intranasal administration is effective and avoids needlestick risks 6, 7, 8
  • Naloxone has an excellent safety profile even if administered to someone without opioid intoxication 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Opioid Overdose Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Intranasal administration of naloxone by paramedics.

Prehospital emergency care, 2002

Research

Intranasal naloxone administration for treatment of opioid overdose.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.